To evaluate the efficacy of AXT914 for ADH1, we undertook in vitro and in vivo studies involving the nuclear flecks (Nuf) mouse model, which has hypocalcemia in association with a germline gain-of-function CaSR mutation, Leu723Gln (27). The gene discussed is CASR; the disease is Hypocalcemia.